Avidin-biotin system for delivery of diagnostic agents

Advanced Drug Delivery Reviews

Volumn 37, Issue 1-3, 1999, Pages 89-101

  Sakahara, Harumi ^a   Saga, Tsuneo ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Avidin; Biotin; Monoclonal antibody; Pretargeting; Radioimmunoguided surgery; Radioimmunoimaging; Radioimmunotherapy; Radionuclide; Streptavidin

Indexed keywords

AGENTS; ANTIGENS; DRUG THERAPY; IMMUNOLOGY; MEDICAL IMAGING; MONOCLONAL ANTIBODIES; PROTEINS; SURGERY; VITAMINS;

AVIDIN BIOTIN SYSTEM; DIAGNOSTIC AGENTS; PRETARGETING; RADIOIMMUNOGUIDED SURGERY; RADIOIMMUNOIMAGING; RADIOIMMUNOTHERAPY; RADIONUCLIDE; STREPTAVIDIN;

CONTROLLED DRUG DELIVERY;

ANTIBODY CONJUGATE; AVIDIN; BIOTIN; BIOTIN DERIVATIVE; DIAGNOSTIC AGENT; EDETIC ACID; FLUORINE 18; GALLIUM 67; INDIUM 111; IODINE 125; IODINE 131; MONOCLONAL ANTIBODY; PENTETATE INDIUM IN 111; PENTETIC ACID; RADIOACTIVE IODINE; RADIOISOTOPE; STREPTAVIDIN; TECHNETIUM 99M; TUMOR ANTIGEN; YTTRIUM 90;

ANIMAL EXPERIMENT; ANIMAL MODEL; BINDING AFFINITY; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG TARGETING; HUMAN; IMAGING; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; REVIEW; SURGERY; TECHNIQUE; TUMOR;

EID: 0344527897     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00101-X     Document Type: Review

References (77)

1. D. Colcher, R. Bird, M. Roselli, K.D. Hardman, S. Johnson, S. Pope, S.W. Dodd, M.W. Pantoliano, D.E. Milenic, J. Schlom, In vivo tumor targeting of a recombinant single-chain antigen-binding protein, J. Natl. Cancer Inst. 82 (1990) 1191-1197.
2. G.P. Adams, J.E. McCartney, M.S. Tai, H. Oppermann, J.S. Huston, W.F. Stafford, M.A. Bookman, I. Fand, L.L. Houston, L.M. Weiner, Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv, Cancer Res. 53 (1993) 4026-4034.
3. S. Hu, L. Shively, A. Raubitschek, M. Sherman, L.E. Williams, J.Y. Wong, J.E. Shively, A.M. Wu, Minibody: a novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts, Cancer Res. 56 (1996) 3055-3061.
4. D. Marshall, R.B. Pedley, J.A. Boden, R. Boden, R.H. Begent, Clearance of circulating radio-antibodies using streptavidin or second antibodies in a xenograft model, Br. J. Cancer 69 (1994) 502-507.
5. 90Y radioimmunotherapy, Cancer Res. 54 (1994) 5937-5946.
6. P. Peltier, C. Curtet, C.F. Chatal, J.M. Le-Doussal, G. Daniel, G. Aillet, A. Gruaz-Guyon, J. Barbet, M. Delaage, Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer, J. Nucl. Med. 34 (1993) 1267-1273.
7. M. Wilchek, E.A. Bayer, The avidin-biotin complex in bioanalytical applications, Anal. Biochem. 171 (1988) 1-32.
8. R.J. DeLange, Egg white avidin. I. Amino acid composition: sequence of the amino- and carboxyl-terminal cyanogen bromide peptides, J. Biol. Chem. 245 (1970) 907-916.
9. R.C. Bruch, H.B. White, Compositional and structural heterogeneity of avidin glycopeptides, Biochemistry 21 (1982) 5334-5341.
10. B. Schechter, R. Silberman, R. Arnon, M. Wilchek, Tissue distribution of avidin and streptavidin injected to mice. Effect of avidin carbohydrate, streptavidin truncation and exogenous biotin, Eur. J. Biochem. 189 (1990) 327-331.
11. S.F. Rosebrough, Pharmacokinetics and biodistribution of radiolabeled avidin, streptavidin and biotin, Nucl. Med. Biol. 20 (1993) 663-668.
12. S.F. Rosebrough, F. Hartley, Biochemical modification of streptavidin and avidin: in vitro and in vivo analysis, J. Nucl. Med. 37 (1996) 1380-1384.
13. D.J. Hnatowich, B. Fritz, F. Virzi, G. Mardirossian, M. Rusckowski, Improved tumor localization with (strept)avidin and labeled biotin as a substitute for antibody, Nucl. Med. Biol. 20 (1993) 189-195.
14. M. Rusckowski, B. Fritz, D.J. Hnatowich, Localization of infection using streptavidin and biotin: an alternative to nonspecific polyclonal immunoglobulin, J. Nucl. Med. 33 (1992) 1810-1815.
15. Z. Yao, M. Zhang, H. Sakahara, T. Saga, Y. Arano, J. Konishi, Avidin targeting of intraperitoneal tumor xenografts, J. Natl. Cancer Inst. 90 (1998) 25-29.
16. G. Paganelli, M. Malcovati, F. Fazio, Monoclonal antibody pretargetting techniques for tumour localization: the avidin-biotin system, Nucl. Med. Commun. 12 (1991) 211-234.
17. D.J. Hnatowich, F. Virzi, M. Rusckowski, Investigations of avidin and biotin for imaging applications, J. Nucl. Med. 28 (1987) 1294-1302.
18. N.M. Green, Avidin, Adv. Protein Chem. 29 (1975) 85-133.
19. H. Kobayashi, H. Sakahara, M. Hosono, Z.-S. Yao, S. Toyama, K. Endo, J. Konishi, Improved clearance of radio-labeled biotinylated monoclonal antibody following the infusion of avidin as a chase without decreased accumulation in the target tumor, J. Nucl. Med. 35 (1994) 1677-1684.
20. Z. Yao, M. Zhang, H. Sakahara, T. Saga, H. Kobayashi, Y. Nakamoto, S. Toyama, J. Konishi, Increased streptavidin uptake in tumors pretargeted with biotinylated antibody using a conjugate of streptavidin-Fab fragment, Nucl. Med. Biol. 25 (1998) 557-560.
21. W.N. Ngai, R.M. Reilly, J. Polihronis, B. Shpitz, In vitro and in vivo evaluation of streptavidin immunoconjugates of the second generation TAG-72 monoclonal antibody CC49, Nucl. Med. Biol. 22 (1995) 77-86.
22. 111In-DTPA-Biocytin, Nucl. Med. Biol. 23 (1996) 459-466.
23. S.F. Rosebrough, M. Hashmi, Galactose-modified streptavidin-GC4 antifibrin monoclonal antibody conjugates:application for two-step thrombus/embolus imaging, J. Pharmacol. Exp. Ther. 276 (1996) 770-775.
24. H. Karacay, R.M. Sharkey, S.V. Govindan, W.J. McBride, D.M. Goldenberg, H.J. Hansen, G.L. Griffiths, Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development, Bioconjugate Chem. 8 (1997) 585-594.
25. W.W. van Osdol, C. Sung, R.L. Dedrick, J.N. Weinstein, A distributed pharmacokinetic model of two-step imaging and treatment protocols: application to streptavidin-conjugated monoclonal antibodies and radiolabelled biotin, J. Nucl. Med. 34 (1993) 1552-1564.
26. F. Virzi, B. Fritz, M. Rusckowski, M. Gionet, H. Misra, D.J. Hnatowich, New indium-111 labeled biotin derivatives for improved immunotargeting, Int. J. Rad. Appl. Instrum. B. 18 (1991) 719-726.
27. E. Livaniou, G.P. Evangelatos, D.S. Ithakissios, Radioiodinated biotin derivatives for in vitro radioassays, J. Nucl. Med. 28 (1987) 1430-1434.
28. R.K. Garlick, R.W. Giese, Avidin binding of radiolabeled biotin derivatives, J. Biol. Chem. 263 (1988) 210-215.
29. 125I]Iodoaniline: a useful reagent for radiolabeling biotin, Nucl. Med. Biol. 19 (1992) 297-301.
30. R.B. del Rosario, R.L. Wahl, Biotinylated iodo-polylysine for pretargeted radiation delivery, J. Nucl. Med. 34 (1993) 1147-1151.
31. Z.P. Kortylewicz, J. Baranowska-Kortylewicz, S.J. Adelstein, A.D. Carmel, A.I. Kassis, Radiolabeled biotin amides from trizenbyl precursors: synthesis, binding, and in-vivo properties, J. Labelled Compounds Radiopharm. 34 (1994) 1129-1146.
32. C.F. Foulon, K.L. Alston, M.R. Zalutsky, Synthesis and preliminary biological evaluation of (3-iodobenzoyl)norbiotinamide and ((5-iodo-3-pyridinyl)carbonyl)norbiotinamide: two radioiodinated biotin conjugates with improved stability, Bioconjugate Chem. 8 (1997) 179-186.
33. D.S. Wilbur, D.K. Hamlin, P.M. Pathare, S.A. Weerawarna, Biotin reagents for antibody pretargeting. Synthesis, radioiodination, and in vitro evaluation of water soluble, biotinidase resistant biotin derivatives, Bioconjugate Chem. 8 (1997) 572-584.
34. 99mTc]PnAO-biotin, Eur. J. Nucl. Med. 21 (1994) 314-321.
35. 67GA deferoxamineacetylcysteinylbiotin, Drug. Metab. Disposition 23 (1995) 1362-1367.
36. T.M. Shoup, A.J. Fischman, S. Jaywook, J.W. Babich, H.W. Strauss, D.R. Elmaleh, Synthesis of fluorine-18-labeled biotin derivatives: biodistribution and infection localization, J. Nucl. Med. 35 (1994) 1685-1690.
37. F.-M. Su, L.M. Gustavson, D.B. Axworthy, L.J. Lyen, L.J. Theodore, A.R. Fritzberg, J.M. Reno, Characterization of a new Y-90 labeled DOTA-biotin for pretargeting, J. Nucl. Med. 36 (1995) 154P.
38. 90Y-labelled biotins using three-step tumour targeting, Nucl. Med. Commun. 18 (1997) 176-182.
39. 211At]astatoanilide, Nucl. Med. Biol. 24 (1997) 135-143.
40. J. Hymes, B. Wolf, Biotinidase and its roles in biotin metabolism, Clin. Chim. Acta 255 (1996) 1-11.
41. F.-T. Liu, N.J. Leonard, Avidin-biotin interaction. Synthesis, oxidation, and spectroscopic properties of linked models, J. Am. Chem. Soc. 101 (1979) 996-1005.
42. N.M. Green, Avidin and streptavidin, Methods Enzymol. 184 (1990) 51-67.
43. L. Chaiet, F.J. Wolf, The properties of streptavidin a biotin binding protein produced by streptomycetes, Arch. Biochem. Biophys. 106 (1964) 1-5.
44. A.I. Kassis, P.L. Jones, K.Z. Matalka, S.J. Adelstein, Antibody-dependent signal amplification in tumor xenografts after pretreatment with biotinylated monoclonal antibody and avidin or streptavidin, J. Nucl. Med. 37 (1996) 343-352.
45. D.A. Goodwin, C.F. Meares, M.J. McCall, M. McTigue, W. Chaovapong, Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens, J. Nucl. Med. 29 (1988) 226-234.
46. A.L. Klibanov, A.V. Martynov, M.A. Slinkin, I.Yu. Sakharov, M.D. Smirnov, V.R. Muzykantov, S.M. Danilov, V.P. Torchilin, Blood clearance of radiolabeled antibody: enhancement by lactosamination and treatment with biotin-avidin or anti-mouse IgG antibodies, J. Nucl. Med. 29 (1988) 1951-1956.
47. V.V. Sinitsyn, A.G. Mamontova, Y.Y. Checkneva, A.A. Shnyra, S.P. Domogatsky, Rapid blood clearance of biotinylated IgG after infusion of avidin, J. Nucl. Med. 30 (1989) 66-69.
48. H. Kobayashi, H. Sakahara, K. Endo, Z.-S. Yao, S. Toyama, J. Konishi, Repeating the avidin 'chase' markedly improved the biodistribution of radiolabeled biotinylated antibodies and promoted the excretion of additional background radioactivity, Eur. J. Cancer 31A (1995) 1689-1696.
49. H. Kobayashi, H. Sakahara, K. Endo, M. Hosono, Z.S. Yao, S. Toyama, J. Konishi, Comparison of the chase effects of avidin, streptavidin, neutravidin, and avidin-ferritin on a radiolabeled biotinylated anti-tumor monoclonal antibody, Jpn. J. Cancer Res. 86 (1995) 310-314.
50. 2 fragments of an anti-tumour antibody, Br. J. Cancer 71 (1995) 18-24.
51. H. Breitz, B. Ratliff, J. Reno, D. Axworthy, A. Fritzberg, F.-M. Su, J. Appelbaum, S. Kunz, C. Seiler, P. Weiden, Performance of antibody streptavidin pretargeting in patients: initial results, J. Nucl. Med. 36 (1995) 225P.
52. M.V. Pimm, H.F. Fells, A.C. Perkins, R.W. Baldwin, Iodine-131 and indium-111 labelled avidin and streptavidin for pre-targeted immunoscintigraphy with biotinylated anti-tumour monoclonal antibody, Nucl. Med. Commun. 9 (1988) 931-941.
53. L.A. Khawli, M.M. Alauddin, G.K. Miller, A.L. Epstein, Improved immunotargeting of tumors with biotinylated monoclonal antibodies and radiolabeled streptavidin, Antibody Immunoconj. Radiopharmaceuticals 6 (1993) 13-27.
54. T. Saga, J.N. Weinstein, J.M. Jeong, T. Heya, J.T. Lee, N. Le, C.H. Paik, C. Sung, R.D. Neumann, Two-step targeting of experimental lung metastases with biotinylated antibody and radiolabeled streptavidin, Cancer Res. 54 (1994) 2160-2165.
55. D.S. Wilbur, D.K. Hamlin, R.L. Vessella, J.E. Stray, K.R. Buhier, P.S. Stayton, L.A. Klumb, P.M. Pathare, S.A. Weerawarna, Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin, Bioconjugate Chem. 7 (1996) 689-702.
56. Z. Yao, M. Zhang, H. Kobayashi, H. Sakahara, H. Nakada, I. Yamashina, J. Konishi, Improved targeting of radiolabeled streptavidin in tumors pretargeted with biotinylated monoclonal antibodies through an avidin chase, J. Nucl. Med. 36 (1995) 837-841.
57. M. Zhang, H. Sakahara, Z. Yao, T. Saga, Y. Nakamoto, N. Sato, H. Nakada, I. Yamashina, J. Konishi, Intravenous avidin chase improved localization of radiolabeled streptavidin in intraperitoneal xenograft pretargeted with biotinylated antibody, Nucl. Med. Biol. 24 (1997) 61-64.
58. C. Sung, W.W. van-Osdol, Pharmacokinetic comparison of direct antibody targeting with pretargeting protocols based on streptavidin-biotin binding, J. Nucl. Med. 36 (1995) 867-876.
59. 111In-DTPA-biotin, Nucl. Med. Biol. 25 (1998) 95-99.
60. R.M. Sharkey, H. Karacay, G.L. Griffiths, T.M. Behr, R.D. Blumenthal, M.J. Mattes, H.J. Hansen, D.M. Goldenberg, Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model, Bioconjugate Chem. 8 (1997) 595-604.
61. H.P. Kalofonos, M. Rusckowski, D.A. Siebecker, G.B. Sivolapenko, D. Snook, J.P. Lavender, A.A. Epenetos, D.J. Hnatowich, Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication, J. Nucl. Med. 31 (1990) 1791-1796.
62. G. Paganelli, S. Pervez, A.G. Siccardi, G. Rowlinson, G. Deleide, F. Chiolerio, M. Malcovati, G.A. Scassellati, A.A. Epenetos, Intraperitoneal radio-localization of tumors pretargeted by biotinylated monoclonal antibodies, Int. J. Cancer 45 (1990) 1184-1189.
63. M. Zhang, Z. Yao, H. Sakahara, T. Saga, Y. Nakamoto, N. Sato, S. Zhao, H. Nakada, I. Yamashina, J. Konishi, Effect of administration route and dose of streptavidin or biotin on the tumor uptake of radioactivity in intraperitoneal tumor with multi-step targeting, Nucl. Med. Biol. 25 (1998) 101-105.
64. M. Zhang, Z. Yao, T. Saga, H. Sakahara, Y. Nakamoto, N. Sato, H. Nakada, I. Yamashina, J. Konishi, Improved intratumoral penetration of radiolabeled streptavidin in intraperitoneal tumor pretargeted with biotinylated antibody, J. Nucl. Med. 39 (1998) 30-33.
65. G. Paganelli, P. Magnani, F. Zito, E. Villa, F. Sudati, L. Lopalco, C. Rossetti, M. Malcovati, F. Chiolerio, E. Seccamani, A.G. Siccardi, F. Fazio, Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients, Cancer Res. 51 (1991) 5960-5966.
66. A.G. Siccardi, G. Paganelli, A.E. Pontiroli, M. Pelagi, P. Magnani, G. Viale, G. Faglia, F. Fazio, In vivo imaging of chromogranin A-positive endocrine tumours by three-step monoclonal antibody targeting, Eur. J. Nucl. Med. 23 (1996) 1455-1459.
67. P. Magnani, G. Paganelli, C. Songini, A. Samuel, F. Sudati, A.G. Siccardi, F. Fazio, Pretargeted immunoscintigraphy in patients with medullary thyroid carcinoma, Br. J. Cancer 74 (1996) 825-831.
68. G. Paganelli, C. Grana, M. Chinol, C. De Cicco, M. Cremonesi, L. Tarditi, Franceschini, S. Zoboli, F. De Braud, A.G. Siccardi, Therapy trial in malignant glioma patients with Y-90-biotin in a 3-step pretargeting approach, J. Nucl. Med. 37 (1996) 169P-170P.
69. P. Magnani, G. Paganelli, G. Modorati, F. Zito, C. Songini, F. Sudati, P. Koch, H.R. Maecke, R. Brancato, A.G. Siccardi, F. Fazio, Quantitative comparison of direct antibody labeling and tumor pretargeting in uveal melanoma, J. Nucl. Med. 37 (1996) 967-971.
70. H.S. Stoldt, F. Aftab, M. Chinol, G. Paganelli, F. Luca, A. Testori, J.G. Geraghty, Pretargeting strategies for radioimmunoguided tumour localisation and therapy, Eur. J. Cancer 33 (1997) 186-192.
71. A.R. Fritzberg, Antibody pretageted radiotherapy: a new approach and a second chance, J. Nucl. Med. 39 (1998) 20N-36N.
72. D. Colcher, J. Esteban, J.A. Carrasquillo, P. Sugarbaker, J.C. Reynolds, G. Bryant, S.M. Larson, J. Schlom, Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma, Cancer Res. 47 (1987) 4218-4224.
73. B.G. Ward, S.J. Mather, L.R. Hawkins, M.E. Crowther, J.H. Shepherd, M. Granowska, K.E. Britton, M.L. Slevin, Localization of radioiodine conjugated to the monoclonal antibody HMFG2 in human ovarian carcinoma: assessment of intravenous and intraperitoneal routes of administration, Cancer Res. 47 (1987) 4719-4723.
74. F. Crippa, G.L. Buraggi, E. Di Re, M. Gasparini, E. Seregni, S. Canevari, M. Gadina, M. Presti, A. Marini, E. Seccamani, Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody, Eur. J. Cancer 27 (1991) 724-729.
75. G. Paganelli, C. Belloni, P. Magnani, F. Zito, A. Pasini, I. Sassi, M. Meroni, M. Mariani, M. Vignali, A.G. Siccardi, F. Fazio, Two-step tumour targeting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptavidin, Eur. J. Nucl. Med. 19 (1992) 322-329.
76. J.Q. Chen, S.E. Strand, J. Tennvall, L. Lindgren, C. Hindorf, H.O. Sjogren, Extracorporeal immunoadsorption compared to avidin chase: enhancement of tumor-to-normal tissue ratio for biotinylated rhenium-188-chimeric BR96, J. Nucl. Med. 38 (1997) 1934-1939.
77. G. Paganelli, M. Stella, F. Zito, P. Magnani, P. De-Nardi, F. Mangili, D. Baratti, F. Veglia, V. Di-Carlo, A.G. Siccardi, F. Fazio, Radioimmunoguided surgery using iodine-125-labeled biotinylated monoclonal antibodies and cold avidin, J. Nucl. Med. 35 (1994) 1970-1975.